mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.44 |
2e-34 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.42 |
3e-27 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.35 |
5e-20 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
6e-20 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
4e-14 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
5e-14 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
9e-14 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-13 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
3e-13 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-12 |